DDIT3 and retinoblastoma: The western blot results demonstrated that the expression of the marker proteins IRE1α, BiP, p-eIF2α, ATF4, and CHOP was upregulated in a dose-dependent manner in retinoblastoma cells after xanthatin treatment (Figure 6).